新闻|New Objective联合再生元建立以PicoChip为标准的免疫肽分析平台

2022 年 10 月 13 日——马萨诸塞州利特尔顿（美国）纳流和微流LC-MS创新解决方案的全球领导者New Objective， Inc宣布与Regeneron Pharmaceuticals（再生元制药公司）合作，将PicoChip作为免疫肽分析的标准平台。New Objective首席执行官Mike Lee率领的New Objective代表团访问了Regeneron制药公司位于纽约塔里敦的园区，庆祝New Objective平台的启动，并正式建立PicoChip作为免疫肽分析的首要解决方案。

Mike与New Objective总裁兼联合创始人Emily Ehrenfeld、Research Fellow兼联合创始人Gary Valaskovic以及业务发展总监Steve Klohr一起会见了Regeneron Pharmaceuticals的科学家兼肿瘤免疫组学、传染病和自身免疫组学负责人Robert Salzler。Robert接待了New Objective代表团，并将他们介绍给他的团队和同事。Rober引导双方团队进行实验室参观，双方团队近距离观察了配备Heated PicoChip的New Objective通用流量工作站，并就进一步创新进行公开的协作讨论。

Robert多年来一直是New Objective的客户，他强调了New Objective的性能 —— “无与伦比”和“没有其它产品能像它一样” ——基于标志性的SilicaTip技术和对核心产品的可重建性和耐用性的持续创新引领。

当 Robert 分享了他们对分析样品价值的见解时——“与患者直接相关并产生影响”—— PicoChip 的集成性和易用性闪现在脑海中，它使你高枕无忧，因为你知道“它有效”。

对于领导这些定量分析的Robert和他的团队来说，他们可以专注于患者本身——收集来自患者的关键数据通过质谱分析（像CPU一样）打印分析数据并讲述关于健康的故事。对于Regeneron来说，这是一条通过创新治疗和疗法通往健康的途径。

New Objective将在定于 11 月举行的网络研讨会上介绍罗伯特。这项活动将以CPSA Everyday的形式推出，与最近由西北大学的Rafa Melani和西北大学Feinberg医学院的Justyna Zakaria领导的网络研讨会形式一致。

October 13, 2022 – Littleton, MA (USA) New Objective, Inc, the global leader in innovative solutions for nanoflow and microflow LC-MS announces the launch of PicoChip as the standard platform for immunopeptidomic analysis at Regeneron Pharmaceuticals. Mike Lee, CEO, New Objective, led a delegation of colleagues from New Objective to visit Regeneron Pharmaceuticals at their campus in Tarrytown, New York, to celebrate the launch and formalize the establishment of the New Objective platform as the premier solution for the immunopeptidomic workflow.

Mike, joined by New Objective colleagues Emily Ehrenfeld, President and Co-Founder, Gary Valaskovic, Research Fellow and Co-Founder, and Steve Klohr, Director of Business Development, met with Robert Salzler, Scientist at Regeneron Pharmaceuticals and Team Leader for Immunopeptidomics for Oncology, Infectious Disease and Autoimmunity. Robert hosted the New Objective team and introduced them to his team and colleagues inclusive of a laboratory tour, where each team could observe the New Objective Universal Flow Station equipped with the heated PicoChip and share an open, collaborative discussion on further innovation.

Robert, who has been a New Objective customer for several years has highlighted the performance of New Objective – “uncomparable” and “no others like it” – focusing on the elements of reproducibility and ruggedness at the core of its product portfolio and built on the standard of the iconic SilicaTip emitter. As Robert shared insights into the value of the samples they analyze – with direct connection and impact to the patient – the elements of integration and ease-of-use of the PicoChip were punctuated with the peace of mind knowing simply “it works”. And for Robert and team leading these quantitative analyses, their focus can remain on the patient via the critical data they are generating and enable the mass spectrometer, like a CPU, to print data and tell the story of health or for Regeneron, a pathway to health via innovative treatments and therapies.

New Objective will be featuring Robert in a webinar scheduled for November. This New Objective event will build on the format as launched through CPSA Everyday and highlighted with recent webinars as led by Rafa Melani at Northwestern University and Justyna Zakaria at Northwestern University Feinberg School of Medicine.